Ampio Pharmaceuticals $3 Million Securities Settlement

If you purchased or otherwise acquired Ampio's common stock between December 29, 2020, and August 2, 2022, you may be eligible to claim an award from a class action settlement.

Ampio Pharmaceuticals, Inc. has agreed to pay $3,000,000 to settle a class action lawsuit for alleged misleading statements regarding its commercial drug candidate, Ampion®.

Who can file a claim?

To be a Settlement Class Member, you:

• Purchased or otherwise acquired Ampio common stock between December 29, 2020, and August 2, 2022.
• Suffered damages as a result of the acquisition.

How much can class members get?

The estimated average recovery per share is approximately $0.015 after deductions for court-approved fees and expenses. The actual recovery will depend on several factors, including the total number of claims submitted and the timing of your stock transactions.

• Initial Purchase Period: If you purchased shares between December 29, 2020, and April 20, 2022, the estimated price inflation was $0.16 per share.
• Subsequent Periods: The inflation amount decreased over time, affecting the potential recovery amount.

How to claim an award

To claim an award, you must submit a completed and signed online claim form or download the PDF claim form and mail it to the Claims Administrator.

Ampio Pharmaceuticals Securities Settlement Claims Administrator

P.O. Box 25226

Santa Ana, CA 92799

Ensure your claim is postmarked or received by January 13, 2025.

$3 Million Settlement fund

The settlement fund of $3,000,000 will cover:

• Attorneys' fees of 28% of the Settlement Fund.
• Up to $75,000 for expenses incurred by Lead Counsel.
• Up to $5,000 for Lead Plaintiffs' reasonable costs and expenses.
• Remaining funds will be distributed to eligible class members.

Important dates

• Deadline to File a Claim: January 13, 2025
• Final Approval Hearing: February 19, 2025

When is the Ampio Pharmaceuticals Settlement payout date?

The court will hold a final approval hearing on February 19, 2025. If the settlement is approved, payments will be distributed to eligible claimants. Ensure your claim is submitted by the deadline to participate in the settlement.

Why is there a class action settlement?

The lawsuit alleged that Ampio Pharmaceuticals made materially false and misleading statements about its drug candidate Ampion®, leading to an inflated stock price. The settlement avoids the uncertainty and expense of further litigation.